| 000 | 01574nam a2200397 a 4500 | ||
|---|---|---|---|
| 001 | EBC3376667 | ||
| 003 | MiAaPQ | ||
| 006 | m o d | | ||
| 007 | cr cn||||||||| | ||
| 008 | 950316s1995 dcu sb f000 0 eng | ||
| 010 | _z 95068327 | ||
| 020 | _z0309052793 | ||
| 035 | _a(MiAaPQ)EBC3376667 | ||
| 035 | _a(Au-PeEL)EBL3376667 | ||
| 035 | _a(CaPaEBR)ebr10056943 | ||
| 035 | _a(CaONFJC)MIL19292 | ||
| 035 | _a(OCoLC)923265432 | ||
| 040 |
_aMiAaPQ _cMiAaPQ _dMiAaPQ |
||
| 050 | 4 |
_aRC848.H44 _bR48 1995 |
|
| 082 | 0 | 4 |
_a616.3/623061 _220 |
| 245 | 0 | 0 |
_aReview of the Fialuridine (FIAU) clinical trials _h[electronic resource] / _cFrederick J. Manning and Morton Swartz, editors. |
| 260 |
_aWashington, DC : _bNational Academy Press, _c1995. |
||
| 300 | _aix, 269 p. | ||
| 500 | _a"Committee to Review the Fialuridine (FIAU/FIAC) Clinical Trials, Division of Health Sciences Policy, Institute of Medicine". | ||
| 504 | _aIncludes bibliographical references (p. 165-177). | ||
| 533 | _aElectronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. | ||
| 650 | 0 |
_aHepatitis B _xChemotherapy _xEvaluation. |
|
| 650 | 0 |
_aFialuridine _xTesting. |
|
| 650 | 0 |
_aFiacitabine _xTesting. |
|
| 650 | 0 |
_aClinical trials _xSafety measures. |
|
| 655 | 4 | _aElectronic books. | |
| 700 | 1 | _aManning, Frederick J. | |
| 700 | 1 | _aSwartz, Morton N. | |
| 710 | 2 | _aProQuest (Firm) | |
| 856 | 4 | 0 |
_uhttps://ebookcentral.proquest.com/lib/nird-ebooks/detail.action?docID=3376667 _zClick to View |
| 999 |
_c29633 _d29633 |
||